CONFERENCE SPEAKERS

Speakers
Helene Vioix
Helene Vioix
Director Global Evidence & Value Development Oncology,
Merck KGaA

Experienced leader in HEOR field with deep understanding of local and national payer’s needs, with a track record of unique initiatives which lead to sustainable impact for the brand, the companies, the HCPs and ultimately to the patients. Helene is driven by improving health management of chronic conditions/ oncology and optimizing treatment pathway by deep understand of health data and their use with internal and external governance.


Inha Kim
Inha Kim
Vice President, Head of Global Strategy and Communication, Medical Affairs,,
Lundbeck


Vandana Ayyar-Gupta
Vandana Ayyar-Gupta
Scientific Adviser, Data & Analytics,
National Institute for Health, and Care Excellence


Iroda Jurabekova
Iroda Jurabekova
Global Pricing and Market Access Lead,
Boehringer Ingelheim


Nivedita Valentine
Nivedita Valentine
Global Associate Vice President, Product Innovation,
Pharmanovia


Ralf Patsch
Ralf Patsch
Head of Real-World Data Business Germany,
Cegedim

Ralf has more than 30 years of experience in Data analysis, marketing and consulting for the pharmaceutical industry. In the course of his career, he has worked as an international consultant for many pharmaceutical companies with a focus on big data, statistics, analyses and return on investment. Ralf started his career at the US pharmaceutical manufacturing company Upjohn. He has been with Cegedim Health Data since 2020, having previously worked i.a. for IMS Health, Kantar Health, Cegedim Strategic Data and as High-Performance Coach. Graduating from the International Management School (Intermas), he holds an MBA and is a book author.


Senior Representative, Flatiron Health
Senior Representative, Flatiron Health
,


Senior Representative, Cascador Health
Senior Representative, Cascador Health
,


Senior Representative, Numerus
Senior Representative, Numerus
,


Sandeep Kiri
Sandeep Kiri
UCB Global Payer Value Strategy- Head of Health Economics and HTA Evidence,
UCB

Sandeep Kiri has over thirteen years of experience in market access with a strong focus on health economics and health technology assessment. He has been in the global function at UCB for five years and is currently the Global Head of Health Economics and HTA Evidence with a keen focus on developing the right evidence for payers in order to demonstrate the full value of interventions.


Lewis Carpenter
Lewis Carpenter
Director Real World Evidence,
Arcturis Data


Gustavo Olivera
Gustavo Olivera
HEOR (Health Economics & Outcomes Research) Senior Expert,
Sanofi


Craig Currie
Craig Currie
Honorary Professor of Pharmacoepidemiology,
Cardiff University


Rocío Casado Seminario
Rocío Casado Seminario
European Affairs and Evidence Generation Head, ,
European Cancer Organisation (ECO)


Sabrina de Souza
Sabrina de Souza
Associate Director, Real World Data Scientist (CMS, PRWE),
Merck